AXIM BIOTECHNOLOGIES, INC. (AXIM) Net margin 2015–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) net profit margin by fiscal year — reported net income divided by reported revenue.
-20395.0%FY2023 · since FY2015: -20539.2% → -20395.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -20395.0% | +49948.1 pp |
| FY2022 | -70343.1% | -43825.9 pp |
| FY2021 | -26517.2% | — |
| FY2019 | -806.5% | +2646.6 pp |
| FY2018 | -3453.0% | +5308.7 pp |
| FY2017 | -8761.7% | +3584.3 pp |
| FY2016 | -12346.0% | +8193.2 pp |
| FY2015 | -20539.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice